Showing 1 - 8 results of 8 for search 'Moyo-Gwete, T', query time: 0.03s
Refine Results
-
1
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies. by Cathrine Scheepers, Prudence Kgagudi, Nonkululeko Mzindle, Elin S Gray, Thandeka Moyo-Gwete, Bronwen E Lambson, Brent Oosthuysen, Batsirai Mabvakure, Nigel J Garrett, Salim S Abdool Karim, Lynn Morris, Penny L Moore
Published 2022-09-01
Article -
2
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination by Boitumelo M. Motsoeneng, Boitumelo M. Motsoeneng, Nelia P. Manamela, Nelia P. Manamela, Haajira Kaldine, Haajira Kaldine, Prudence Kgagudi, Prudence Kgagudi, Tandile Hermanus, Tandile Hermanus, Frances Ayres, Frances Ayres, Zanele Makhado, Zanele Makhado, Thandeka Moyo-Gwete, Thandeka Moyo-Gwete, Mieke A. van der Mescht, Fareed Abdullah, Fareed Abdullah, Michael T. Boswell, Veronica Ueckermann, Theresa M. Rossouw, Shabir A. Madhi, Shabir A. Madhi, Shabir A. Madhi, Penny L. Moore, Penny L. Moore, Penny L. Moore, Simone I. Richardson, Simone I. Richardson
Published 2023-08-01
Article -
3
Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme—The South African Experience by Tanya Nadia Glatt, Caroline Hilton, Cynthia Nyoni, Avril Swarts, Ronel Swanevelder, James Cowley, Cordelia Mmenu, Thandeka Moyo-Gwete, Penny L. Moore, Munzhedzi Kutama, Jabulisile Jaza, Itumeleng Phayane, Tinus Brits, Johan Koekemoer, Ute Jentsch, Derrick Nelson, Karin van den Berg, Marion Vermeulen
Published 2021-10-01
Article -
4
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells by Robert G. E. Krause, Thandeka Moyo-Gwete, Simone I. Richardson, Zanele Makhado, Nelia P. Manamela, Tandile Hermanus, Nonhlanhla N. Mkhize, Roanne Keeton, Ntombi Benede, Mathilda Mennen, Sango Skelem, Farina Karim, Khadija Khan, Catherine Riou, Ntobeko A. B. Ntusi, Ameena Goga, Glenda Gray, Willem Hanekom, Nigel Garrett, Linda-Gail Bekker, Andreas Groll, Alex Sigal, Penny L. Moore, Wendy A. Burgers, Alasdair Leslie
Published 2023-08-01
Article -
5
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection. by Thandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, Tandile Hermanus, Holly Spencer, Nelia P Manamela, Frances Ayres, Zanele Makhado, Thopisang Motlou, Marius B Tincho, Ntombi Benede, Amkele Ngomti, Richard Baguma, Masego V Chauke, Mathilda Mennen, Marguerite Adriaanse, Sango Skelem, Ameena Goga, Nigel Garrett, Linda-Gail Bekker, Glenda Gray, Ntobeko A B Ntusi, Catherine Riou, Wendy A Burgers, Penny L Moore
Published 2023-11-01
Article -
6
Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivity by Ntombi Benede, Marius B. Tincho, Avril Walters, Vennesa Subbiah, Amkele Ngomti, Richard Baguma, Claire Butters, Lina Hahnle, Mathilda Mennen, Sango Skelem, Marguerite Adriaanse, Heidi Facey-Thomas, Christiaan Scott, Jonathan Day, Timothy F. Spracklen, Strauss van Graan, Sashkia R. Balla, Thandeka Moyo-Gwete, Penny L. Moore, Rae MacGinty, Maresa Botha, Lesley Workman, Marina Johnson, David Goldblatt, Heather J. Zar, Ntobeko A.B. Ntusi, Liesl Zühlke, Kate Webb, Catherine Riou, Wendy A. Burgers, Roanne S. Keeton
Published 2024-01-01
Article -
7
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, do... by Madhi, SA, Koen, AL, Izu, A, Fairlie, L, Cutland, CL, Baillie, V, Padayachee, SD, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Aley, PK, Bhikha, S, Hermanus, T, Horne, E, Jose, A, Kgagudi, P, Lambe, T, Masenya, M, Masilela, M, Mkhize, N, Moultrie, A, Mukendi, CK, Moyo-Gwete, T, Nana, AJ, Nzimande, A, Patel, F, Rhead, S, Taoushanis, C, Thombrayil, A, van Eck, S, Voysey, M, Villafana, TL, Vekemans, J, Gilbert, SC, Pollard, AJ, Moore, PL, Kwatra, G
Published 2021Journal article -
8
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants. by Catherine Riou, Jinal N Bhiman, Yashica Ganga, Shobna Sawry, Frances Ayres, Richard Baguma, Sashkia R Balla, Ntombi Benede, Mallory Bernstein, Asiphe S Besethi, Sandile Cele, Carol Crowther, Mrinmayee Dhar, Sohair Geyer, Katherine Gill, Alba Grifoni, Tandile Hermanus, Haajira Kaldine, Roanne S Keeton, Prudence Kgagudi, Khadija Khan, Erica Lazarus, Jean Le Roux, Gila Lustig, Mashudu Madzivhandila, Siyabulela F J Magugu, Zanele Makhado, Nelia P Manamela, Qiniso Mkhize, Paballo Mosala, Thopisang P Motlou, Hygon Mutavhatsindi, Nonkululeko B Mzindle, Anusha Nana, Rofhiwa Nesamari, Amkele Ngomti, Anathi A Nkayi, Thandeka P Nkosi, Millicent A Omondi, Ravindre Panchia, Faeezah Patel, Alessandro Sette, Upasna Singh, Strauss van Graan, Elizabeth M Venter, Avril Walters, Thandeka Moyo-Gwete, Simone I Richardson, Nigel Garrett, Helen Rees, Linda-Gail Bekker, Glenda Gray, Wendy A Burgers, Alex Sigal, Penny L Moore, Lee Fairlie
Published 2024-01-01
Article